Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by smcaptraderon May 21, 2009 2:01pm
306 Views
Post# 16006850

Last kick at the can

Last kick at the canSSS seems to have exhausted their news releases till the end of the year near term pullback is to be expected but it was a great day to trade. No news coming, interest will be lost.



TEM CELL THERAPEUTICS CORP. RELEASES ENCOURAGING CLINICAL RESULTS AND PROVIDES CORPORATE UPDATE

As a result of the U.S. Food and Drug Administration (FDA) lifting thephase IIb clinical hold as reported in Stockwatch May 15, 2009, andencouraging results from the phase IIb patients enrolled prior to theclinical hold, Stem Cell Therapeutics Corp. (SCT) has decided tocommence the modified phase IIb Regenesis clinical stroke trial as soonas possible, with the goal of completing patient enrolment by the endof 2009.

Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse